About Kenneth Lee, Jr.
Form D filings for Aerami Therapeutics in 2020 list Kenneth Lee, Jr. as director.
Kenneth Lee, Jr. first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Kenneth Lee, Jr. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kenneth Lee, Jr. works with at each company, as listed on that company's latest Form D.
Aerami Therapeutics Holdings, Inc. · Form D, Jun 17, 2020
TC
Timm Crowder
Executive officer
AW
Anne Whitaker
Executive officer and director
BW
Bill Welch
Director
BW
Benjamin Wolin
Director
ST
Steve Thornton
Director
MK
Michael Kaseta
Chief Financial Officer
JP
John Patton
Director
AS
Adam Stern
Director